{"id":"W3088162954","doi":"10.1016/j.annonc.2020.08.675","title":"561P Phase Ib study of ribociclib (R) + trametinib (T) in patients (pts) with metastatic/advanced solid tumours","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Oncology; Regimen; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Trametinib; Adverse effect; Gastroenterology; Urology; Chemotherapy; Kinase; MAPK/ERK pathway","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002067426,0.0002010713,0.001065092,0.0001402433,0.00001850936,0.000001845751,0.0001505842,0.00005281253,0.00008702363],"category_scores_gemma":[0.0002246544,0.0001644873,0.00007190748,0.0004401297,0.0001906735,0.0001203886,0.00004192627,0.0002276693,0.000004449949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004372246,"about_ca_system_score_gemma":0.0002050694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003893371,"about_ca_topic_score_gemma":0.00005765008,"domain_scores_codex":[0.9981929,0.0001632466,0.000661971,0.000334906,0.0003260018,0.0003209836],"domain_scores_gemma":[0.9985592,0.0001756717,0.0004764068,0.0002483975,0.0003700705,0.0001702859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0737381,0.04715321,0.1438578,0.0004462265,0.001364003,0.0004141271,0.03399137,0.001988939,0.011196,0.0001129922,0.0003589998,0.6853782],"study_design_scores_gemma":[0.2520415,0.3814205,0.2529535,0.000389966,0.000724193,0.00003927332,0.02915142,0.0002856142,0.06813748,0.000492679,0.01356094,0.0008029686],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954873,0.0001704823,0.0001338231,0.002620934,0.00004798458,0.001055025,0.00003634121,0.00002451784,0.0004235556],"genre_scores_gemma":[0.9956828,0.00002819687,0.002441308,0.001689995,0.00003250965,0.00005793407,0.00001846326,0.0000338324,0.0000149268],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6845753,"threshold_uncertainty_score":0.6707597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09530483402239531,"score_gpt":0.4358727483727366,"score_spread":0.3405679143503413,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}